tiprankstipranks
BioLargo (BLGO)
:BLGO
US Market
Holding BLGO?
Track your performance easily

BioLargo (BLGO) Stock Price & Analysis

60 Followers

BLGO Stock Chart & Stats


Financials

Annual

Ownership Overview

9.96%0.04%90.00%
Mutual Funds
0.04% Other Institutional Investors
90.00% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

BLGO FAQ

What was BioLargo ’s price range in the past 12 months?
BioLargo lowest stock price was $0.16 and its highest was $0.45 in the past 12 months.
    What is BioLargo ’s market cap?
    BioLargo ’s market cap is $87.04M.
      When is BioLargo ’s upcoming earnings report date?
      BioLargo ’s upcoming earnings report date is Mar 27, 2025 which is in 68 days.
        How were BioLargo ’s earnings last quarter?
        BioLargo released its earnings results on Nov 14, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.002.
          Is BioLargo overvalued?
          According to Wall Street analysts BioLargo ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does BioLargo pay dividends?
            BioLargo does not currently pay dividends.
            What is BioLargo ’s EPS estimate?
            BioLargo ’s EPS estimate is 0.
              How many shares outstanding does BioLargo have?
              BioLargo has 301,179,170 shares outstanding.
                What happened to BioLargo ’s price movement after its last earnings report?
                BioLargo reported an EPS of -$0.002 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of BioLargo ?
                  Currently, no hedge funds are holding shares in BLGO
                  ---

                  BioLargo Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  52.65%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -27.06%
                  Trailing 12-Months
                  Asset Growth
                  57.45%
                  Trailing 12-Months

                  Company Description

                  BioLargo

                  BioLargo, Inc. engages in the provision of technology solutions for odor and moisture control, disinfection, and water treatment. It operates through the following segments: Odor-No-More and BLEST, Clyra, and Biolargo. The Odor-No-More and BLEST segment generates cash by selling products and services. The Clyra Medical obtains cash from third party investments of sales of its common stock. The BioLargo Water generates cash through government research grants and tax credits. The company was founded in 1989 and is headquartered in Westminster, CA.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Kraig Biocraft Laboratories
                  Flotek
                  Nanophase Technologies
                  ASP Isotopes, Inc.
                  Arq Inc
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis